Open Demat Account Now

Contact
Us

Open an
Account

Login to
trade

Account
Activation

Markets

Offerings

Research

HNI Advisory

Trading platforms

Business Associates

Media Center

Customer Services

Track your Application

Home
>
Markets
>
Company Information
>
Quarterly Results

Quarterly Results

Change Company Go

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code:	532331	NSE Symbol:	AJANTPHARM	P/E(TTM):	41.8
ISIN Demat:	INE031B01049	Div & Yield %:	1.81	EPS(TTM):	68.36
Book Value (Rs ):	282.5572901	Market Cap (Rs Cr.):	35690.51	Face Value(Rs):	2

Quarters :

((र) In Cr)

Particulars	Sep 2024 (Rs Cr.)	Jun 2024 (Rs Cr.)	Mar 2024 (Rs Cr.)	Dec 2023 (Rs Cr.)
Gross Sales	1128.91	1077.27	926.07	1085.29
Other Operating Income	0.00	0.00	0.00	0.00
Other Income	40.34	28.37	33.68	13.73
Total Income	1169.25	1105.64	959.75	1099.02
Total Expenditure	826.00	761.44	698.92	758.11
PBIDT	343.25	344.20	260.83	340.91
Interest	0.73	0.72	1.42	2.36
PBDT	342.52	343.48	259.41	338.55
Depreciation	33.32	32.92	33.47	33.41
Tax	71.13	71.42	59.83	81.94
Fringe Benefit Tax	0.00	0.00	0.00	0.00
Deferred Tax	3.09	3.11	3.42	3.05
Reported Profit After Tax	234.98	236.03	162.69	220.15
Extra-ordinary Items	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	234.98	236.03	162.69	220.15

EPS (Unit Curr.)	18.75	18.77	12.92	17.48
EPS (Adj) (Unit Curr.)	18.75	18.77	12.92	17.48
Calculated EPS (Unit Curr.)	18.75	18.83	12.88	17.42
Calculated EPS (Adj) (Unit Curr.)	18.75	18.83	12.88	17.42
Calculated EPS (Ann.) (Unit Curr.)	74.98	75.32	51.50	69.70
Calculated EPS (Adj) (Ann.) (Unit Curr.)	74.98	75.32	51.50	69.70
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend (%)	1400.00	0.00	0.00	1300.00
Equity	25.07	25.07	25.27	25.27
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	2.00	2.00	2.00	2.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

PBIDTM(%)	30.41	31.95	28.17	31.41
PBDTM(%)	30.34	31.88	28.01	31.19
PATM(%)	20.81	21.91	17.57	20.28

Stock Market

Useful Links

Other Links

Filing complaints on SCORES - Easy & quick

Register on Scores portal - https://scores.sebi.gov.in/
Mandatory details for filing complaints on SCORES
1. Name, PAN, Address, Mobile Number, Email ID
Benefits:
1. Effective communication
2. Speedy redressal of the grievances
Please refer https://scores.gov.in/scores/Welcome.html for more information.

Welcome To IDBI Direct

IDBI CAPITAL MARKETS & SECURITIES LTD. (IDBI Capital), a wholly owned subsidiary of IDBI Bank Ltd., is a fully integrated financial services provider catering to the needs of retail, institutional and corporate clients. Incorporated in December 1993, today it has a net-worth of around INR 3 billion and employs over 200 employees in 17 branches, spread over 17 cities across India. The Retail Broking & Distribution division of IDBI Capital offers online trading in Equities, F&O, Mutual Funds and IPOs, through the investing portal, www.idbidirect.in. We also distribute various Third Party Products, like Fixed Income Products, Mutual Funds, etc. We are amongst the top 10 MF distributors in India.

SEBI Regn. Nos.: NSE (CM, F&O, CD) -INZ000007237 | BSE (CM, F&O) - INZ000007237 | IDBI Capital Markets & Securities Limited is AMFI Registered Mutual Fund distributor our AMFI Regn No. ARN 0893 valid till January 19, 2025 | NSDL DP ID: IN300079 | NSE Member Code - 07066 | BSE Clg. No - 84 | For Complaints & Grievances Mail to : redressal@idbicapital.com

IDBI CAPITAL MARKETS & SECURITIES LTD. 6th Floor, IDBI Tower, World Trade Center, Cuffe Parade, Mumbai 400 005, India.

Tel: (+022) 022 40691700 | Email - info@idbidirect.in

"IDBI Capital is distributor for Mutual Funds and IPOs"
"Investment in securities market are subject to market risks, read all the related documents carefully before investing."

Reporting of Cyber Incidents
Helpline Number – 18002003388/022- 022-3913 5001 – Option (3) Dedicated Email Id – cyberalert@idbicapital.com

Copyright © 2016 All rights Reserved IDBI CAPITAL MARKETS & SECURITIES LTD
Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )